Chemotherapeutic agent Cisplatin monitoring in biological fluids by means of inductively-coupled plasma emission spectrometry (ICP-AES)
- 1 August 1986
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 158 (3) , 207-215
- https://doi.org/10.1016/0009-8981(86)90284-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- High-performance liquid chromatographic determination of platinum (II) in plasma ultrafiltrate and urine: comparison with a flameless atomic absorption spectrometric methodClinica Chimica Acta; International Journal of Clinical Chemistry, 1984
- The determination of platinum in biological fluid by means of graphite furnace atomic absorption spectrometryClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- Determination of Platinum in Serum and Ultrafiltrate by Flameless Atomic Absorption SpectrophotometryJournal of Pharmaceutical Sciences, 1981
- Analysis of Total Platinum in Tissue Samples by Flameless Atomic Absorption Spectrophotometry. Elimination of the Need for Sample DigestionAnalytical Letters, 1981
- Kinetics of cis‐dichlorodiammineplatinumClinical Pharmacology & Therapeutics, 1979
- Platinum nephrotoxicityThe American Journal of Medicine, 1978
- Development of a Specific Analytical Method forCis-Dichlorodiammineplatinum (II) in PlasmaAnalytical Letters, 1978
- Diaminodichloroplatinum: A phase I study showing responses in testicular and other tumorsCancer, 1974
- Platinum Compounds: a New Class of Potent Antitumour AgentsNature, 1969
- Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum ElectrodeNature, 1965